In:
Science, American Association for the Advancement of Science (AAAS), Vol. 378, No. 6615 ( 2022-10-07), p. 68-78
Kurzfassung:
A single-nucleotide polymorphism in a brain-specific enhancer is directly responsible for increasing the risk of glioma.
Materialart:
Online-Ressource
ISSN:
0036-8075
,
1095-9203
DOI:
10.1126/science.abj2890
Sprache:
Englisch
Verlag:
American Association for the Advancement of Science (AAAS)
Publikationsdatum:
2022
ZDB Id:
128410-1
ZDB Id:
2066996-3
ZDB Id:
2060783-0
SSG:
11
Permalink